Bapa Sitaram Ayurvedic & Health Care Products Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 13-01-2025
- Paid Up Capital ₹ 0.10 M
as on 13-01-2025
- Company Age 5 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -98.71%
(FY 2022)
- Profit 91.42%
(FY 2022)
- Ebitda 82.02%
(FY 2022)
- Net Worth -8.33%
(FY 2022)
- Total Assets -0.09%
(FY 2022)
About Bapa Sitaram Ayurvedic & Health Care Products
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Avaniben Goswami and Prernaba Rana serve as directors at the Company.
- CIN/LLPIN
U24304GJ2019PTC109362
- Company No.
109362
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Aug 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Bhavnagar, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bapa Sitaram Ayurvedic & Health Care Products?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Avaniben Goswami  | Director | 29-May-2024 | Current |
| Prernaba Rana | Director | 29-May-2024 | Current |
Financial Performance of Bapa Sitaram Ayurvedic & Health Care Products.
Bapa Sitaram Ayurvedic & Health Care Products Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 98.71% decrease. The company also saw a substantial improvement in profitability, with a 91.42% increase in profit. The company's net worth dipped by a decrease of 8.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bapa Sitaram Ayurvedic & Health Care Products?
Unlock access to Bapa Sitaram Ayurvedic & Health Care Products's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Bapa Sitaram Innovation & Technology Private LimitedActive 3 years 10 months
Prernaba Rana is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bapa Sitaram Ayurvedic & Health Care Products?
Unlock and access historical data on people associated with Bapa Sitaram Ayurvedic & Health Care Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bapa Sitaram Ayurvedic & Health Care Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bapa Sitaram Ayurvedic & Health Care Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
